Ethyl 8-benzoyl-6-chloro-4-hydroxyquinoline-3-carboxylate

Catalog No. :
ACLIRI724
CAS No. :
192513-59-0
Molecular Formula :
C19H14ClNO4
Molecular Weight :
355.78

IUPAC Name:ethyl 8-benzoyl-6-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate

Ethyl 8-benzoyl-6-chloro-4-hydroxyquinoline-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$565.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 8-benzoyl-6-chloro-4-hydroxyquinoline-3-carboxylate
IUPAC Nameethyl 8-benzoyl-6-chloro-4-oxo-1,4-dihydroquinoline-3-carboxylate
MDL No.MFCD00665089
Molecular FormulaC19H14ClNO4
Molecular Weight355.78
SMILESO=C(C1=C(O)C2=CC(Cl)=CC(C(C3=CC=CC=C3)=O)=C2N=C1)OCC
InChI KeyDZSFJSUIVYNDOS-UHFFFAOYSA-N
Synonym8-Benzoyl-6-chloro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid ethyl ester;ETHYL 8-BENZOYL-6-CHLORO-4-HYDROXY-3-QUINOLINECARBOXYLATE;3-Quinolinecarboxylic acid, 8-benzoyl-6-chloro-4-hydroxy-, ethyl ester
CAS No.192513-59-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLIRI724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHIRG246 route compound structure diagram
    ACHIRG24687-13-8 In Stock
  2. Plus
  3. ACXSOW189 route compound structure diagram
    ACXSOW189719-59-5 In Stock
  4. Then
  5. ACLIRI724 route product structure diagram
    ACLIRI724192513-59-0
Inquiry

2. ACLIRI724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIRI724 route product structure diagram
    ACLIRI724192513-59-0
Inquiry

Comments (0)